Download video

Tofacitinib in AxSpA in Developing Countries

No views

RheumNow

7 days ago

Tofacitinib in AxSpA in Developing Countries

Tofacitinib in AxSpA in Developing Countries

TB and opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis
5:10
TB and opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis
by Annals of the Rheumatic Diseases
Discussing Rheumatology: Tofacitinib safety and dose-switching in RA
7:32
Discussing Rheumatology: Tofacitinib safety and dose-switching in RA
by The Immune-Mediated Inflammatory Disease Forum
FDA Approves tofacitinib for Treatment of Active Ankylosing Spondylitis
1:21
FDA Approves tofacitinib for Treatment of Active Ankylosing Spondylitis
by Medical Dialogues
Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors
4:55
Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors
by Annals of the Rheumatic Diseases
Video Abstract: Efficacy and Safety of Tofacitinib in AS by Baseline C-Reactive Protein Level
10:48
Video Abstract: Efficacy and Safety of Tofacitinib in AS by Baseline C-Reactive Protein Level
by The Journal of Rheumatology
Rheumat TV : Tofacitinib: Friend or Foe ? by Dr Abhishek Zanwar
47:00
Rheumat TV : Tofacitinib: Friend or Foe ? by Dr Abhishek Zanwar
by Ortho TV : Orthopaedic Video Channel
Efficacy and safety of tofacitinib following inadequate response to conventional antirheumatic drugs
6:02
Efficacy and safety of tofacitinib following inadequate response to conventional antirheumatic drugs
by Annals of the Rheumatic Diseases
Effects of tofacitinib with or without MTX on MRI endpoints in patients with early active RA
5:52
Effects of tofacitinib with or without MTX on MRI endpoints in patients with early active RA
by Annals of the Rheumatic Diseases
Video Abstract: Impact of Tofacitinib on Components of the ACR Response Criteria
6:44
Video Abstract: Impact of Tofacitinib on Components of the ACR Response Criteria
by The Journal of Rheumatology
Tofacitinib in AxSpA in Developing Countries
2:47
Tofacitinib in AxSpA in Developing Countries
by RheumNow
RheumNow Podcast – Tofacitinib Safety Concerns (2.5.2021)
16:29
RheumNow Podcast – Tofacitinib Safety Concerns (2.5.2021)
by RheumNow
Recent advances in management of Rheumatoid Arthritis: focus on Tofacitinib
35:56
Recent advances in management of Rheumatoid Arthritis: focus on Tofacitinib
by Ortho TV : Orthopaedic Video Channel
Tofacitinib Promising in Rheumatoid Arthritis
1:55
Tofacitinib Promising in Rheumatoid Arthritis
by MDedge: news and insights for busy physicians
Tofacitinib and RA-ILD
3:33
Tofacitinib and RA-ILD
by RheumNow
TLL-018 (a JAK1\/TYK2 agent) vs. Tofacitinib in RA
5:49
TLL-018 (a JAK1\/TYK2 agent) vs. Tofacitinib in RA
by RheumNow
Rheumatoid Arthritis \& Tofacitinib
3:13
Rheumatoid Arthritis \& Tofacitinib
by KGD Life
Tofabest 5 mg Tab. (Tofacitinib 5mg ), PCD franchise
1:16
Tofabest 5 mg Tab. (Tofacitinib 5mg ), PCD franchise
by Arlak Biotech Pvt Ltd
Discussing Rheumatology: Tofacitinib Improves PROs
9:34
Discussing Rheumatology: Tofacitinib Improves PROs
by The Immune-Mediated Inflammatory Disease Forum